My watch list
my.bionity.com  
Login  
MARKET STUDIES

Egm International, Inc. - Strategic SWOT Analysis Review

This comprehensive SWOT profile of Egm International, Inc. provides you with an in-depth strategic analysis of the company's businesses and operat ...

Oral Cancer – Pipeline Review, H1 2012

Introduction Global Markets Direct’s, 'Oral Cancer - Pipeline Review, H1 2012', provides an overview of the Oral Cancer therapeutic pipeline. Th ...

GE Measurement & Control Solutions - Strategic SWOT Analysis Review

GE Measurement & Control Solutions is a technology instruments company, engaged in the design, manufacture and sale of the advanced sensing and me ...

Orthostatic Hypotension - Pipeline Review, Q2 2011

Introduction Global Markets Direct’s, 'Orthostatic Hypotension - Pipeline Review, Q2 2011', provides an overview of the Orthostatic Hypotension t ...

Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Ben ...

GBI Research, the leading business intelligence provider, has released its latest research “Autoimmune Disorders Therapeutics Market to 2017 - Lau ...

Current market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains negative. That aside, BMI emphasises that the number-one concern for drugmakers in 201 ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psoriasis. It includes an overview of the tri ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also involved in providing various health care services. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AI ... more

China Chinese Prepared Medicines Mfg. Industry Profile

Through a comparative analysis on the development of Chinese prepared medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the Chinese prepared medicines mfg. industry in China, a list of ma ... more

Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018

Introduction ”Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile ENT Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment ... more

News on market trends
  • Merck to acquire Natrix Separations

    Merck announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography. The transaction is expected to close in Q3 of 2017. Financial details were not disclosed. Natrix is known for its unique more

  • EMA prepares for Brexit

    The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. “Preparing for the move, managing the necessary more

  • Advanced Enzymes acquires evoxx

    The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a binding agreement about the acquisition of 100% stake in evoxx technologies. evoxx technologies is more

  • Eurofins expands in India

    Eurofins Scientific announces that it has signed an exclusive agreement with Tata Group to acquire Advinus Therapeutics, a preclinical and clinical phase contract research company for Safety Assessment, DMPK, CMC services, and Analytical R&D Services. The transaction is expected to close in the next more

  • Start-ups profit from being in close contact with the venture capital scene

    High-Tech Gründerfonds, Bayer Pharma AG, Merck KGaA and the Innovation and Startup Center for Biotechnology (IZB) hosted the 3rd Munich Life Science Pitch Day at the IZB. Eight start-up teams had the opportunity to present their pioneering projects in front of 15 renowned venture capital and pharmac more

  • Honeybee, wasp and hornet venom extract shortage

    Millions of Floridians will celebrate the Fourth of July holiday outdoors with family, fireworks, barbecues and some irksome, uninvited guests: stinging, flying insects. Allergists in Florida and across the nation are particularly concerned about those party crashers this year because of a shortage more

  • Merck expands biotech capacities

    Merck inaugurated a new packaging building at its biotech manufacturing site of Aubonne, Switzerland. The inauguration ceremony was attended by Merck’s Chairman of the Executive Board and CEO Stefan Oschmann, as well as personalities from the local political, economic and scientific scene. “This sta more

  • TiGenix opens US headquarters

    TiGenix NV announces it has opened an U.S. office in Cambridge, Massachusetts. Establishing U.S. operations is a significant step for TiGenix and will support its strategic goal of developing and commercializing its lead product, Cx601, for the treatment of complex perianal fistulas in Crohn's disea more

  • Three shows, one date

    Messe Muenchen India and Indian Pharma Machinery Manufacturers Association (IPMMA) has entered into a collaboration agreement to collocate analytica Anacon India, India Lab Expo and PHARMA Pro & Pack Expo in 2017. All three trade fairs will take place simultaneously from September 21–23, 2017 at HIT more

  • c-LEcta signs Sales and Distribution Agreement with Cosmo Bio for Japan

    Cosmo Bio Co., Ltd. and the German biotechnology specialist c-LEcta GmbH, announce the signing of a sales and distribution agreement for c-LEcta’s DENARASE®, a high-quality nuclease for the removal of all forms of DNA and RNA in biopharmaceutical processes. Based on this agreement, DENARASE® will no more

New market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenari ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also invol ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE